19-40394181-G-C

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_181882.3(PRX):​c.4171C>G​(p.Arg1391Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000202 in 1,587,630 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1391Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000079 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000014 ( 0 hom. )

Consequence

PRX
NM_181882.3 missense

Scores

1
17

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: -1.03

Publications

3 publications found
Variant links:
Genes affected
PRX (HGNC:13797): (periaxin) This gene encodes a protein involved in peripheral nerve myelin upkeep. The encoded protein contains 2 PDZ domains which were named after PSD95 (post synaptic density protein), DlgA (Drosophila disc large tumor suppressor), and ZO1 (a mammalian tight junction protein). Two alternatively spliced transcript variants have been described for this gene which encode different protein isoforms and which are targeted differently in the Schwann cell. Mutations in this gene cause Charcot-Marie-Tooth neuoropathy, type 4F and Dejerine-Sottas neuropathy. [provided by RefSeq, Jul 2008]
PRX Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease type 4
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Charcot-Marie-Tooth disease type 4F
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • Charcot-Marie-Tooth disease type 3
    Inheritance: AD, AR Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.033591002).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_181882.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRX
NM_181882.3
MANE Select
c.4171C>Gp.Arg1391Gly
missense
Exon 7 of 7NP_870998.2
PRX
NM_001411127.1
c.4456C>Gp.Arg1486Gly
missense
Exon 7 of 7NP_001398056.1
PRX
NM_020956.2
c.*4376C>G
3_prime_UTR
Exon 6 of 6NP_066007.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRX
ENST00000324001.8
TSL:1 MANE Select
c.4171C>Gp.Arg1391Gly
missense
Exon 7 of 7ENSP00000326018.6
PRX
ENST00000291825.11
TSL:1
c.*4376C>G
3_prime_UTR
Exon 6 of 6ENSP00000291825.6
PRX
ENST00000674005.2
c.4456C>Gp.Arg1486Gly
missense
Exon 7 of 7ENSP00000501261.1

Frequencies

GnomAD3 genomes
AF:
0.0000789
AC:
12
AN:
152122
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000213
AC:
5
AN:
234688
AF XY:
0.0000236
show subpopulations
Gnomad AFR exome
AF:
0.000257
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000935
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000139
AC:
20
AN:
1435390
Hom.:
0
Cov.:
30
AF XY:
0.0000141
AC XY:
10
AN XY:
710498
show subpopulations
African (AFR)
AF:
0.000245
AC:
8
AN:
32714
American (AMR)
AF:
0.0000237
AC:
1
AN:
42160
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24536
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39288
South Asian (SAS)
AF:
0.00
AC:
0
AN:
83440
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52652
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5620
European-Non Finnish (NFE)
AF:
0.00000730
AC:
8
AN:
1096000
Other (OTH)
AF:
0.0000509
AC:
3
AN:
58980
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.523
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000788
AC:
12
AN:
152240
Hom.:
0
Cov.:
33
AF XY:
0.0000403
AC XY:
3
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.000193
AC:
8
AN:
41544
American (AMR)
AF:
0.000261
AC:
4
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5156
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67996
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.542
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000531
Hom.:
0
Bravo
AF:
0.000121
ExAC
AF:
0.0000330
AC:
4

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Apr 30, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.4171C>G (p.R1391G) alteration is located in exon 7 (coding exon 4) of the PRX gene. This alteration results from a C to G substitution at nucleotide position 4171, causing the arginine (R) at amino acid position 1391 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

Charcot-Marie-Tooth disease type 4F Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.

Charcot-Marie-Tooth disease type 4 Uncertain:1
Apr 07, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 1391 of the PRX protein (p.Arg1391Gly). This variant is present in population databases (rs369072136, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with PRX-related conditions. ClinVar contains an entry for this variant (Variation ID: 242185). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.088
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
0.91
DANN
Benign
0.93
DEOGEN2
Benign
0.17
T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.082
N
LIST_S2
Benign
0.67
T
M_CAP
Benign
0.0049
T
MetaRNN
Benign
0.034
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
0.90
L
PhyloP100
-1.0
PrimateAI
Benign
0.43
T
PROVEAN
Benign
-1.9
N
REVEL
Benign
0.040
Sift
Benign
0.043
D
Sift4G
Uncertain
0.0040
D
Polyphen
0.019
B
Vest4
0.27
MutPred
0.20
Loss of MoRF binding (P = 0.0115)
MVP
0.22
MPC
0.29
ClinPred
0.017
T
GERP RS
-2.2
Varity_R
0.063
gMVP
0.51
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs369072136; hg19: chr19-40900088; API